- Home
- NOW vs AZN Comparison
NOW vs AZN Comparison
Compare NOW & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOW
- AZN
- Stock Information
- Founded
- NOW 2004
- AZN 1992
- Country
- NOW United States
- AZN United Kingdom
- Employees
- NOW N/A
- AZN N/A
- Industry
- NOW Computer Software: Prepackaged Software
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- NOW Technology
- AZN Health Care
- Exchange
- NOW Nasdaq
- AZN Nasdaq
- Market Cap
- NOW 209.5B
- AZN 228.9B
- IPO Year
- NOW 2012
- AZN 1993
- Fundamental
- Price
- NOW $938.01
- AZN $71.13
- Analyst Decision
- NOW Strong Buy
- AZN Strong Buy
- Analyst Count
- NOW 32
- AZN 3
- Target Price
- NOW $1,055.13
- AZN $95.00
- AVG Volume (30 Days)
- NOW 1.3M
- AZN 4.0M
- Earning Date
- NOW 07-23-2025
- AZN 07-29-2025
- Dividend Yield
- NOW N/A
- AZN 2.14%
- EPS Growth
- NOW N/A
- AZN 22.71
- EPS
- NOW 7.37
- AZN 4.97
- Revenue
- NOW $11,469,000,000.00
- AZN $54,982,000,000.00
- Revenue This Year
- NOW $19.71
- AZN $9.56
- Revenue Next Year
- NOW $19.35
- AZN $6.09
- P/E Ratio
- NOW $127.36
- AZN $14.30
- Revenue Growth
- NOW 21.01
- AZN 15.48
- 52 Week Low
- NOW $678.66
- AZN $61.24
- 52 Week High
- NOW $1,198.09
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- NOW 34.20
- AZN 51.15
- Support Level
- NOW $992.00
- AZN $69.15
- Resistance Level
- NOW $1,057.39
- AZN $72.46
- Average True Range (ATR)
- NOW 25.68
- AZN 1.00
- MACD
- NOW -7.47
- AZN 0.04
- Stochastic Oscillator
- NOW 3.08
- AZN 59.82
About NOW ServiceNow Inc.
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.